CDK4, a new metabolic sensor that antagonizes AMPK
Cyclin-dependent kinase 4 (CDK4) is a positive regulator of cell cycle progression, however, there is growing evidence demonstrating that its function exceeds the control of cell division. Here we show that CDK4 is an important regulator of cellular substrate utilization through direct inhibition of...
Main Authors: | L. Fajas, I. C. Lopez-Mejia |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-09-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2017.1409862 |
Similar Items
-
Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple‐Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1‐Regulated Cholesterol Metabolism
by: Yilan Yang, et al.
Published: (2025-02-01) -
Synergistic induction of autophagy in gastric cancer by targeting CDK4/6 and MEK through AMPK/mTOR pathway
by: Hong Zhou, et al.
Published: (2024-05-01) -
Re-thinking cell cycle regulators : the cross-talk with metabolism.
by: Lluis eFajas
Published: (2013-01-01) -
De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition
by: Míriam Tarrado‐Castellarnau, et al.
Published: (2017-10-01) -
AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review
by: Dora Višnjić, et al.
Published: (2021-05-01)